393
Participants
Start Date
October 31, 2002
Primary Completion Date
March 31, 2003
Study Completion Date
March 31, 2003
Ibuprofen
800 mg oral tablet three time daily with meals for 6 weeks
celecoxib
200 mg oral capsule once daily with morning meal for 6 weeks
placebo
matched placebo orally for 6 weeks
Pfizer Investigational Site, Brooklyn
Pfizer Investigational Site, Altoona
Pfizer Investigational Site, Newtown
Pfizer Investigational Site, Jenkintown
Pfizer Investigational Site, Danville
Pfizer Investigational Site, Charleston
Pfizer Investigational Site, Mt. Pleasant
Pfizer Investigational Site, Greer
Pfizer Investigational Site, DeLand
Pfizer Investigational Site, Pembroke Pines
Pfizer Investigational Site, Miami
Pfizer Investigational Site, St. Petersburg
Pfizer Investigational Site, Naples
Pfizer Investigational Site, Anniston
Pfizer Investigational Site, Johnson City
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Evansville
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Tulsa
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Layton
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Albuquerque
Pfizer Investigational Site, Las Vegas
Pfizer Investigational Site, Paramount
Pfizer Investigational Site, Long Beach
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, Anaheim
Pfizer Investigational Site, Edison
Pfizer Investigational Site, South Plainfield
Pfizer Investigational Site, New York
Pfizer Investigational Site, Warwick
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY